AtriCure, Inc. (ATRC)
54.54
+1.58
(+2.98%)
USD |
NASDAQ |
Sep 11, 16:00
54.57
+0.03
(+0.06%)
After-Hours: 20:00
AtriCure Market Cap : 2.774B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.774B |
| September 10, 2026 | 2.694B |
| September 09, 2026 | 2.697B |
| September 08, 2026 | 2.733B |
| September 04, 2026 | 2.620B |
| September 03, 2026 | 2.668B |
| September 02, 2026 | 2.675B |
| September 01, 2026 | 2.488B |
| August 31, 2026 | 2.459B |
| August 28, 2026 | 2.469B |
| August 27, 2026 | 2.506B |
| August 26, 2026 | 2.450B |
| August 25, 2026 | 2.476B |
| August 24, 2026 | 2.507B |
| August 21, 2026 | 2.491B |
| August 20, 2026 | 2.415B |
| August 19, 2026 | 2.422B |
| August 18, 2026 | 2.327B |
| August 17, 2026 | 2.277B |
| August 14, 2026 | 2.253B |
| August 13, 2026 | 2.212B |
| August 12, 2026 | 2.216B |
| August 11, 2026 | 2.185B |
| August 10, 2026 | 2.118B |
| August 07, 2026 | 2.105B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.009B |
| August 05, 2026 | 2.001B |
| August 04, 2026 | 1.984B |
| August 03, 2026 | 1.969B |
| July 31, 2026 | 1.921B |
| July 30, 2026 | 2.042B |
| July 29, 2026 | 2.080B |
| July 28, 2026 | 2.022B |
| July 27, 2026 | 1.901B |
| July 24, 2026 | 1.782B |
| July 23, 2026 | 1.678B |
| July 22, 2026 | 1.705B |
| July 21, 2026 | 1.747B |
| July 20, 2026 | 1.761B |
| July 17, 2026 | 1.770B |
| July 16, 2026 | 1.804B |
| July 15, 2026 | 1.749B |
| July 14, 2026 | 1.738B |
| July 13, 2026 | 1.762B |
| July 10, 2026 | 1.736B |
| July 09, 2026 | 1.750B |
| July 08, 2026 | 1.704B |
| July 07, 2026 | 1.661B |
| July 06, 2026 | 1.640B |
| July 02, 2026 | 1.610B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Boston Scientific Corp. | 62.18B |
| Abbott Laboratories | 176.41B |
| AngioDynamics, Inc. | 636.77M |
| Alphatec Holdings, Inc. | 1.615B |
| Baxter International, Inc. | 12.30B |
Market Cap Related Metrics
| PE Ratio | 252.03 |
| PS Ratio | 4.639 |
| Price to Book Value | 5.372 |
| Price to Free Cash Flow | 49.75 |
| Price | 54.54 |
| Earnings Yield | 0.40% |
| Operating PE Ratio | 190.23 |
| Normalized PE Ratio | 236.00 |